# Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma

> clinical trial · VERIFIED · 2026-08-19

Status: RECRUITING · Sponsor: Impact Biotech Ltd · Condition: Locally Advanced Unresectable Pancreatic Adenocarcinoma

- Company: Impact Biotech Ltd
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05919238

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.